The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern?
Open accessAbstract
Silver first gained regulatory approval for use as an antimicrobial agent in the early 20th century, but its usage diminished with the introduction of antibiotics in the 1940s. Recently, however, topical silver has gained popularity once again, principally in the management of open wounds. This has been largely due to the spread of methicillin-resistant Staphylococcus aureus and the resultant reduction in first-line antibiotic prescribing. The increase in the use of topical silver has raised issues concerning silver resistance, together with questions about the standardization of antimicrobial testing methods for silver. Issues related to silver product testing include a failure to establish standard procedures for determining MIC values, an absence of recognized breakpoints, a lack of conformity in the way different products release silver and variations in the effects of microbiological media on silver release and the measurement of inhibitory activity. The clinical incidence of silver resistance remains low, and emergence of resistance can be minimized if the level of silver ions released from products is high and the bactericidal activity rapid.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial silver resistance: molecular biology and uses and misuses of silver compounds
Silver, S. (2003) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(03)00047-0 · Cited by 1,312
Bacterial resistance to silver in wound care
Percival, S. L., Bowler, P. G., & Russell, D. (2005) · Journal of Hospital Infection · doi:10.1016/j.jhin.2004.11.014 · Cited by 867
Silver as biocides in burn and wound dressings and bacterial resistance to silver compounds
Silver, S., Phung, L. T., & Silver, G. (2006) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-006-0139-7 · Cited by 726
Historical review of the use of silver in the treatment of burns. I. Early uses
Klasen, H. J. (2000) · Burns · doi:10.1016/s0305-4179(99)00108-4 · Cited by 719
Fox, C. L. (1968) · Archives of Surgery · doi:10.1001/archsurg.1968.01330200022004 · Cited by 479
Treatment of Large Human Burns With 0.5% Silver Nitrate Solution
MOYER, C. A. (1965) · Archives of Surgery · doi:10.1001/archsurg.1965.01320120014002 · Cited by 476
Molecular basis for resistance to silver cations in Salmonella
Gupta, A., Matsui, K., Lo, J.-F., & Silver, S. (1999) · Nature Medicine · doi:10.1038/5545 · Cited by 473
Principles and practice of disinfection, preservation, and sterilization
Russell, A. D., Hugo, W. B., & Ayliffe, G. A. J. (1992) · Medical Entomology and Zoology · Cited by 467
Gemmell, C. G., Edwards, D. I., Fraise, A. P., Gould, F. K., Ridgway, G. L., & Warren, R. E. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl017 · Cited by 439
Li, X. Z., Nikaido, H., & Williams, K. E. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.19.6127-6132.1997 · Cited by 345
SALMONELLA TYPHIMURIUM RESISTANT TO SILVER NITRATE, CHLORAMPHENICOL, AND AMPICILLIN
Larkin Mchugh, G., Moellering, R., Hopkins, C., & Swartz, M. (1975) · The Lancet · doi:10.1016/s0140-6736(75)91138-1 · Cited by 272
Preparing the wound bed 2003: focus on infection and inflammation.
Sibbald, R. G., Orsted, H. L., Schultz, G. S., Coutts, P. M., & Keast, D. H. (2003) · PubMed · Cited by 201
A comparison of the antimicrobial effects of four silver-containing dressings on three organisms
Thomas, S., & McCubbin, P. (2003) · Journal of Wound Care · doi:10.12968/jowc.2003.12.3.26477 · Cited by 197
Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests
MacGowan, A. P., & Wise, R. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_1.17 · Cited by 187
Diversity of silver resistance genes in IncH incompatibility group plasmids
Gupta, A., Phung, L. T., Silver, S., & Taylor, D. E. (2001) · Microbiology · doi:10.1099/00221287-147-12-3393 · Cited by 169
Plasmid mediated silver resistance in Acinetobacter baumannii
Deshpande, L., & Chopade, B. A. (1994) · BioMetals · doi:10.1007/bf00205194 · Cited by 145
Gentamicin- and silver-resistant pseudomonas in a burns unit.
Bridges, K., Kidson, A., Lowbury, E. J. L., & Wilkins, M. D. (1979) · BMJ · doi:10.1136/bmj.1.6161.446 · Cited by 142
Silver-resistant Enterobacteriaceae from hospital patients
Hendry, A. T., & Stewart, I. O. (1979) · Canadian Journal of Microbiology · doi:10.1139/m79-136 · Cited by 139
Role of aCandida albicansP1-Type ATPase in Resistance to Copper and Silver Ion Toxicity
Riggle, P. J., & Kumamoto, C. A. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.17.4899-4905.2000 · Cited by 130
Preclinical evaluation of novel antibacterial agents by microbiological and molecular techniques
O’Neill, A. J., & Chopra, I. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.8.1045 · Cited by 126
Self-citationFong, J., Wood, F. M., & Fowler, B. (2005) · Burns · doi:10.1016/j.burns.2004.12.009 · Cited by 116
Ug, A., & Ceylan, Ö. (2003) · Archives of Medical Research · doi:10.1016/s0188-4409(03)00006-7 · Cited by 112
An in vitro analysis of the antimicrobial properties of 10 silver-containing dressings
Thomas, S., & McCubbin, P. (2003) · Journal of Wound Care · doi:10.12968/jowc.2003.12.8.26526 · Cited by 109
Silvazine™ (silver sulfadiazine and chlorhexidine) activity against 200 clinical isolates
George, N., FAOAGALI, J. L., & Muller, M. J. (1997) · Burns · doi:10.1016/s0305-4179(97)00047-8 · Cited by 98
Moore, S. L., & Payne, D. N. (2008) · Blackwell Publishing Ltd eBooks · doi:10.1002/9780470755884.ch2 · Cited by 94
Strohal, R., Schelling, M., Takacs, M., JURECKA, W., Gruber, U., & Offner, F. A. (2005) · Journal of Hospital Infection · doi:10.1016/j.jhin.2005.04.001 · Cited by 77
Maple, P. A. C., Hamilton-Miller, J. M. T., & Brumfitt, W. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/29.6.661 · Cited by 74
Annear, D. I., Mee, B. J., & Bailey, M. (1976) · Journal of Clinical Pathology · doi:10.1136/jcp.29.5.441 · Cited by 60
Price, W. R., & Wood, M. (1966) · The American Journal of Surgery · doi:10.1016/0002-9610(66)90103-6 · Cited by 16
Cited by
Silver nanoparticles as a new generation of antimicrobials
Rai, M., Yadav, A., & Gade, A. (2009) · Biotechnology Advances · doi:10.1016/j.biotechadv.2008.09.002 · Cited by 6,173
Mechanistic Basis of Antimicrobial Actions of Silver Nanoparticles
Dakal, T. C., Kumar, A., Majumdar, R. S., & Yadav, V. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01831 · Cited by 2,135
Duncan, T. V. (2011) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2011.07.017 · Cited by 2,029
Huh, A. J., & Kwon, Y. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.002 · Cited by 1,864
Lipsky, B. A., Berendt, A. R., Cornia, P. B., Pile, J. C., Peters, E. J. G., Armstrong, D. G., Deery, H. G., Embil, J. M., Joseph, W. S., Karchmer, A. W., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis346 · Cited by 1,766
Metadata
- Authors
- Chopra, I.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-02-16
- Volume
- 59
- Issue
- 4
- Pages
- 587-590
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2146818200
- Cited by
- 722
- References
- 29
- FWCI
- 14.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.